Gilliland Jeter Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.81M Sell
1,563
-40
-2% -$47.2K 0.46% 57
2026
Q2
$1.92M Buy
1,603
+11
+0.7% +$11.2K 0.5% 55
2026
Q1
$1.46M Buy
1,592
+15
+1% +$15.2K 0.43% 56
2025
Q4
$1.69M Buy
1,577
+2
+0.1% +$1.91K 0.51% 48
2025
Q3
$1.2M Buy
1,575
+32
+2% +$23.8K 0.37% 58
2025
Q2
$1.2M Buy
1,543
+319
+26% +$248K 0.39% 56
2025
Q1
$1.01M Hold
1,224
– – 0.36% 63
2024
Q4
$945K Sell
1,224
-101
-8% -$83.6K 0.32% 70
2024
Q3
$1.17M Hold
1,325
– – 0.38% 57
2024
Q2
$1.2M Buy
1,325
+237
+22% +$190K 0.4% 58
2024
Q1
$846K Sell
1,088
-66
-6% -$47K 0.29% 75
2023
Q4
$673K Buy
+1,154
New +$674K 0.28% 88

Other funds holding LLY

Gilliland Jeter Wealth Management's LLY Position: Q3 2026 in Review

Gilliland Jeter Wealth Management reduced its Eli Lilly (LLY) stake by 2.5% in Q3 2026, selling an estimated $47.2K and leaving 1,563 shares worth $1.81M. The position accounts for 0.46% of the portfolio, ranked #57.

Gilliland Jeter Wealth Management first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.92M in Q2 2026. 4,600 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Gilliland Jeter Wealth Management held 1,563 shares of Eli Lilly worth $1.81M as of Q3 2026.
  • Gilliland Jeter Wealth Management sold 40 Eli Lilly shares in Q3 2026, an estimated $47.2K.
  • Eli Lilly made up 0.46% of Gilliland Jeter Wealth Management's portfolio in Q3 2026, its #57 holding.
  • Gilliland Jeter Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Gilliland Jeter Wealth Management's Eli Lilly position peaked at $1.92M in Q2 2026.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.